Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€1.61
16.08.23
€13.75
16.08.24
-
18.08.21

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.087
12.08.23
-
12.08.24
48.28%
08.09.23

buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.54
14.07.23
€24.93
14.07.24
-26.38%
02.05.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.46
09.07.23
-
09.07.24
-24.64%
02.05.24

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€0.44
08.07.23
€1.00
08.07.24
6.71%
19.12.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.40
01.07.23
-
01.07.24
-22.08%
02.05.24

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.11
25.06.23
-
25.06.24
13.16%
08.09.23

Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.29
25.06.23
-
25.06.24
-21.77%
06.07.23

Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.13
17.06.23
-
17.06.24
1.57%
08.09.23

Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.35
17.06.23
-
17.06.24
-33.91%
06.07.23

buy
CareRx Corp.

Start price
Target price
Perf. (%)
€1.59
13.06.23
€2.00
13.06.24
-15.72%
13.05.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.63
14.05.23
-
14.05.24
-28.90%
02.05.24

buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
-0.53%
14:47

Could be very worthwhile Investment >20% year
buy
Invictus MD Strategies

Start price
Target price
Perf. (%)
€0.023
28.01.22
-
-
03.03.20

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
15.10.21
€9.00
15.10.24
-75.01%
16:39

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.87
13.10.21
€15.00
13.10.24
-74.78%
16:39

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Small challenges to pay loans and raise capital
Rising EBIT margin expected